ESR1 and breast carcinoma: Therefore, the interaction between estrogen receptor (ER) and the overactivation of PAM pathway enables breast cancer cells to adapt to estrogen deprivation, resulting in desensitization of breast cancer cells to endocrine therapy [5, 7].